UK approves Pfizer-BioNTech COVID-19 Vaccine

UK approves Pfizer-BioNTech COVID-19 Vaccine

The United Kingdom is the first country to approve the use of the Pfizer-BioTech Covit-19 vaccine.

The UK announced on December 2 that the Govt-19 vaccine would be used from next week. Emergency accreditation clarifies the way to use a vaccine that is expected to play a significant role in the global effort to control the corona virus.

"The government today accepted the recommendation of the Independent Pharmaceuticals and Health Products Regulatory Authority (MHRA) to approve the use of Pfizer-Bioentech's Govit-19 vaccine," the government said in a statement.

The vaccine will be available across the UK from next week.

Pfizer and its German ally said in November that the shot, which relied on a new technology called messenger RNA, was 95% effective in the final analysis of clinical-experimental data.

The U.K. The companies also have contracts to deliver hundreds of millions of views to Europe, the US, Japan and elsewhere.